A 7-y-old mixed-breed male dog was presented with a history of generalized lymphadenopathy. Fine-needle aspirates of the enlarged peripheral lymph nodes were suggestive of lymphoma. Histologic examination of a retromandibular lymph node was suggestive of high-grade, medium large-cell lymphoma. Immunohistochemistry revealed concurrent expression of CD3 and CD20. The co-localization of the 2 antigens was confirmed by immunofluorescence. PCR for antigen receptor gene rearrangements (PARR) detected clonal rearrangements for both T-cell receptor gamma and B-cell receptor. The final diagnosis was CD3-CD20-positive anaplastic lymphoma with cross-lineage rearrangement.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649537 | PMC |
| http://dx.doi.org/10.1177/1040638720963132 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Flowcytometric data of intermediate-large cell gastrointestinal lymphoma presenting a gross mass in 32 cats - "let them glow in the flow".
Front Vet Sci
May 2024
Clinical Pathology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, Vienna, Austria.
Article Synopsis
- - Gastrointestinal lymphoma is the most prevalent lymphoma in cats, with aggressive forms being rare and having a poor prognosis; due to sampling challenges, immunophenotyping isn't typically performed.
- - A study involving 32 cats diagnosed and categorized their gastrointestinal lymphomas using flow cytometry immunophenotyping, linking it to the WHO classification and clonality testing.
- - The study found high agreement between histopathology and flow cytometry, with 87.5% of cases showing consistency and positive clonality results in 87.5% of the patients, marking a significant advancement in lymphoma subtype identification.
Characterization of CD3+/CD20+ canine large-cell lymphoma.
J Vet Diagn Invest
January 2024
Charles River Laboratories, Mattawan, MI, USA.
Immunophenotyping of canine large-cell lymphoma (LCL) for B-cell and T-cell surface antigens is commonly performed to better predict the clinical outcome. Expression of surface antigen CD3 is associated with T-cell malignancies; surface antigen CD20 is expressed on B cells. However, a small subset of canine LCLs expresses both CD3 and CD20 (CD3+/CD20+); this form of lymphoma remains poorly defined at the molecular level.
View Article and Find Full Text PDFPrognostic value of cross-lineage expression of the myeloid-associated antigens CD13 and CD33 in adult B-lymphoblastic leukemia: A large real-world study of 1005 patients.
Cancer Med
April 2023
Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, China.
Background: Cross-lineage expression of the myeloid-associated antigens CD13/CD33 is common in adult B-lymphoblastic leukemia (B-ALL) patients, yet its prognostic value is still controversial.
Methods: We conducted a retrospective study of 1005 de novo adult B-ALL patients from January 2009 to December 2019 in our hospital. Logistic and Cox regression were used to analyze the prognostic value of CD13/CD33 expression in B-ALL.
Mott Cell Differentiation in Canine Multicentric B Cell Lymphoma with Cross-Lineage Rearrangement and Lineage Infidelity in a Dog.
Vet Sci
October 2022
Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Korea.
Lymphoma is a severe condition characterized by the proliferation of neoplastic lymphoid cells. A 4-year-old female mongrel dog presented with solitary lymph node enlargement. Significant right prescapular lymphadenopathy and abdominal enlargement were observed during physical examination.
View Article and Find Full Text PDFCase Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With and Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?
Front Oncol
December 2021
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Lineage switch between myeloid and lymphoid in acute leukemia is well established as a mechanism for leukemic cells to escape chemotherapy. Cross-lineage transformation is also recognized in some solid tumors on targeted therapy, such as adenocarcinomas of the lung and prostate that transforms to neuroendocrine carcinoma on targeted therapy. Now lineage plasticity is increasingly recognized in mature lymphomas, such as small B-cell lymphomas transforming to histiocytic/dendritic cell sarcoma.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!